We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
BGC Group
BGC
$5.2B
| $814K | ﹤0.01% |
88,678
+12,500
| +16% | +$117K |
|
1027
ArcBest
ARCB
$3.28B
| $813K | ﹤0.01% |
7,500
+2,500
| +50% | +$274K |
|
1028
Matsons
MATX
$6.39B
| $813K | ﹤0.01% |
5,700
| – | – |
|
1029
Clarivate
CLVT
$1.25B
| $810K | ﹤0.01% |
114,100
+17,900
| +19% | +$114K |
|
1030
Moelis & Co
MC
$5.21B
| $805K | ﹤0.01% |
11,751
| – | – |
|
1031
Visteon
VC
$2.86B
| $805K | ﹤0.01% |
8,451
+1,100
| +15% | +$112K |
|
1032
ICF International
ICFI
$1.6B
| $804K | ﹤0.01% |
4,822
| – | – |
|
1033
Interparfums
IPAR
$3.7B
| $803K | ﹤0.01% |
6,200
+1,900
| +44% | +$238K |
|
1034
Urban Outfitters
URBN
$6.53B
| $799K | ﹤0.01% |
20,853
+7,400
| +55% | +$301K |
|
|
SQSP
1035
DELISTED
Squarespace, Inc.
SQSP
| $799K | ﹤0.01% |
17,200
+600
| +4% | +$26.9K |
|
1036
Ambarella
AMBA
$3.6B
| $798K | ﹤0.01% |
14,144
+4,400
| +45% | +$234K |
|
|
APLS
1037
DELISTED
Apellis Pharmaceuticals
APLS
| $796K | ﹤0.01% |
27,600
+3,700
| +15% | +$137K |
|
|
HBI
1038
DELISTED
Hanesbrands
HBI
| $796K | ﹤0.01% |
108,353
+33,600
| +45% | +$201K |
|
1039
CNO Financial Group
CNO
$5.07B
| $795K | ﹤0.01% |
22,655
| – | – |
|
1040
Shake Shack
SHAK
$2.98B
| $795K | ﹤0.01% |
7,700
| – | – |
|
1041
Agios Pharmaceuticals
AGIO
$2B
| $792K | ﹤0.01% |
17,823
+1,700
| +11% | +$77.2K |
|
1042
Credit Acceptance
CACC
$6.05B
| $792K | ﹤0.01% |
1,786
| – | – |
|
1043
Mueller Water Products
MWA
$3.98B
| $780K | ﹤0.01% |
35,936
-13,400
| -27% | -$270K |
|
1044
Newell Brands
NWL
$2.63B
| $778K | ﹤0.01% |
101,300
+26,600
| +36% | +$191K |
|
1045
Nomad Foods
NOMD
$1.68B
| $776K | ﹤0.01% |
40,700
+7,100
| +21% | +$131K |
|
1046
Travel + Leisure Co
TNL
$4.58B
| $774K | ﹤0.01% |
16,800
| – | – |
|
1047
Acadia Realty Trust
AKR
$2.86B
| $773K | ﹤0.01% |
32,932
+10,500
| +47% | +$224K |
|
|
JBTM
1048
JBT Marel
JBTM
$6.1B
| $773K | ﹤0.01% |
7,851
+1,100
| +16% | +$102K |
|
1049
Acuity Brands
AYI
$10.8B
| $771K | ﹤0.01% |
2,800
| – | – |
|
1050
Pegasystems
PEGA
$5.51B
| $771K | ﹤0.01% |
21,088
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.